These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 2633149
21. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)]. Golyshevskaia VI, El'shanskaia MP. Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650 [Abstract] [Full Text] [Related]
22. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria]. Saito H, Sato K, Tomioka H, Watanabe T. Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537 [No Abstract] [Full Text] [Related]
23. [Radiometric determination of Mycobacterium avium-intracellulare and Mycobacterium xenopi sensitivity to antitubercular agents]. Kubín M, Lindholm-Levy P, Heifets LB. Epidemiol Mikrobiol Imunol; 1994 Sep; 43(3):104-6. PubMed ID: 7953081 [Abstract] [Full Text] [Related]
24. In vitro drug susceptibility of Mycobacterium other than tubercle bacilli. Imwidthaya P, Komolpis P, Suthiravitayavaniz K, Rienthong S. J Med Assoc Thai; 1990 Aug; 73(8):438-42. PubMed ID: 2262746 [Abstract] [Full Text] [Related]
25. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Banks J, Jenkins PA. Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264 [Abstract] [Full Text] [Related]
27. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)]. Kuze F, Lee Y, Maekawa N, Suzuki Y. Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152 [No Abstract] [Full Text] [Related]
29. [Mycobacterial bases of the therapy of mycobacterioses]. Hejný J. Z Erkr Atmungsorgane; 1982 Sep; 158(1-2):163-7. PubMed ID: 7072265 [Abstract] [Full Text] [Related]
31. [Evaluation of clinical efficacy of rifampicin in the treatment of nontuberculous mycobacteriosis from in vitro susceptibility testing]. Tsukamura M. Kekkaku; 1989 Jul; 64(7):453-8. PubMed ID: 2585946 [Abstract] [Full Text] [Related]
37. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Bhusal Y, Shiohira CM, Yamane N. Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578 [Abstract] [Full Text] [Related]
38. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria. Shen GH, Wu BD, Hu ST, Lin CF, Wu KM, Chen JH. Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481 [Abstract] [Full Text] [Related]
39. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order]. Makarevich NM, Rudoĭ NM. Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726 [No Abstract] [Full Text] [Related]
40. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Zimmer BL, DeYoung DR, Roberts GD. Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]